BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32314727)

  • 21. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma.
    Adamson LA; Fowler LJ; Clare-Salzler MJ; Hobbs JA
    Thyroid; 2011 Apr; 21(4):411-7. PubMed ID: 21190433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice.
    Hsu TC; Chiu CC; Chang SC; Chan HC; Shi YF; Chen TY; Tzang BS
    Virulence; 2016; 7(2):110-8. PubMed ID: 26632342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of human amniotic epithelial cells in murine models of Hashimoto's thyroiditis and Systemic lupus erythematosus.
    Tan B; Yuan W; Li J; Yang P; Ge Z; Liu J; Qiu C; Zhu X; Qiu C; Lai D; Guo L; Wang L; Yu L
    Cytotherapy; 2018 Oct; 20(10):1247-1258. PubMed ID: 30174233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice.
    Mori K; Yoshida K; Ishii K; Morohoshi K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S
    Autoimmunity; 2011 Sep; 44(6):483-9. PubMed ID: 21332425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
    Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
    Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
    Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
    J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses.
    Page C; Duverlie G; Sevestre H; Desailloud R
    J Med Virol; 2015 Jan; 87(1):162-9. PubMed ID: 24760746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular method to test if Parvovirus B19 is a new virus to the Old World.
    Lewin Altschuler E
    Med Hypotheses; 2004; 62(5):795-6. PubMed ID: 15082109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.
    Naciute M; Mieliauskaite D; Rugiene R; Nikitenkiene R; Jancoriene L; Mauricas M; Nora-Krukle Z; Murovska M; Girkontaite I
    J Gen Virol; 2016 Dec; 97(12):3302-3312. PubMed ID: 27902343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parvovirus B19 and in situ immune response in eczema and psoriasis skin lesions of patients from the Brazilian Amazon region.
    Simões ACL; de Souza Aarão TL; de Sousa JR; Prudente DL; de Castro YG; Maneschy RB; Fuzii HT; Quaresma JAS
    Microb Pathog; 2018 Apr; 117():27-31. PubMed ID: 29428424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human parvovirus B19 infection in patients with systemic lupus erythematosus.
    Hsu TC; Tsay GJ
    Rheumatology (Oxford); 2001 Feb; 40(2):152-7. PubMed ID: 11257151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis.
    Aslan B; Serin MS; Aslan G; Kalaci A; Yanat AN; Tezcan S; Emekdas G
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):381-5. PubMed ID: 18096351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes.
    Crowson AN; Magro CM; Dawood MR
    J Cutan Pathol; 2000 Nov; 27(10):505-15. PubMed ID: 11100810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature.
    Chabert P; Kallel H
    Eur J Case Rep Intern Med; 2020; 7(12):001729. PubMed ID: 33312992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.
    Franssila R; Auramo J; Modrow S; Möbs M; Oker-Blom C; Käpylä P; Söderlund-Venermo M; Hedman K
    Clin Exp Immunol; 2005 Oct; 142(1):53-61. PubMed ID: 16178856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults.
    Wang J; Zhang W; Liu H; Wang D; Wang W; Li Y; Wang Z; Wang L; Zhang W; Huang G
    J Infect; 2010 May; 60(5):360-70. PubMed ID: 20153771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high prevalence of parvovirus B19 DNA in patients with psoriasis.
    Yazici AC; Aslan G; Baz K; Ikizoglu G; Api H; Serin MS; Tezcan S; Emekdas G; Tasdelen B
    Arch Dermatol Res; 2006 Oct; 298(5):231-5. PubMed ID: 16862431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular analysis for the role of human parvovirus B19 infection in rheumatoid arthritis].
    Ishii K; Ito T; Sasaki T
    Seikagaku; 2006 Mar; 78(3):242-9. PubMed ID: 16634568
    [No Abstract]   [Full Text] [Related]  

  • 39. Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.
    Giraud C; Tatar Z; Soubrier M
    Clin Rheumatol; 2016 Oct; 35(10):2615-8. PubMed ID: 27541023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.
    Bock CT; Klingel K; Aberle S; Duechting A; Lupescu A; Lang F; Kandolf R
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):340-3. PubMed ID: 16316397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.